title: Immunomodulatory and hemagglutinating activities of acidic polysaccharides isolated from Combretum racemosum.
abstract: Extracts of leaves of different species of the genus Combretum have been used historically to treat a variety of medicinal problems. However, little is known about the active components conferring therapeutic properties to these extracts. In the present studies, we evaluated biochemical properties and immunomodulatory activity of polysaccharides isolated from the leaves of Combretum racemosum. Water-soluble polysaccharides from leaves of C. racemosum were extracted and fractionated by DEAE-cellulose and Diaion HP-20 to obtain a Diaion-bound fraction, designated Combretum polysaccharide-acidic bound or CP-AB, which was eluted with methanol, and an unbound fraction, designated as CP-AU. Molecular weight determination, sugar analysis, and other physical and chemical characterization of the fractions were performed. Fraction CP-AU (mol. weight 5.0 kDa) contained type II arabinogalactan and had potent immunomodulatory activity, inducing the production of interleukin (IL)-1β, -6, -10, and tumor necrosis factor-α (TNF-α) by human peripheral blood mononuclear cells (PBMC) and MonoMac-6 monocytic cells. Likewise, intraperitoneal administration of CP-AU increased in vivo serum levels of IL-6 and monocyte chemoattractant protein-1 (MCP-1) in mice. CP-AU-induced secretion of TNF-α in PBMC was prevented by Toll-like receptor 4 (TLR4) antagonist LPS-RS. Treatment with CP-AU induced phosphorylation of Akt2, Akt3, GSK-3β, HSP27, mTOR, and all p38 MAPK isoforms (α, β, δ, and γ), as well as stimulation of AP-1/NF-κB transcriptional activity. In addition, CP-AU effectively agglutinated erythrocytes from several species, including human, mouse, and rabbit. In contrast, fraction CP-AB was inactive in all biological tests, including cytokine production and hemagglutination. These data suggest that at least part of the beneficial therapeutic effects reported for the water extracts of leaves from C. racemosum are due to modulation of leukocyte functions.
authors: Department of Immunology and Infectious Diseases, Montana State University, Bozeman, MT 59717, USA.
authors: Igor A
authors: IA
authors: Schepetkin
authors: Koffi
authors: K
authors: Kouakou
authors: Ahoua
authors: A
authors: Yapi
authors: Liliya N
authors: LN
authors: Kirpotina
authors: Mark A
authors: MA
authors: Jutila
authors: Mark T
authors: MT
authors: Quinn
mesh_terms: D000371:Agglutination / Q000187:drug effects; D000818:Animals; D002460:Cell Line; D029765:Combretum / Q000737:chemistry*; D016207:Cytokines / Q000378:metabolism; D004912:Erythrocytes / Q000187:drug effects; D005685:Galactans / Q000008:administration & dosage* / Q000737:chemistry / Q000302:isolation & purification; D006801:Humans; D007963:Leukocytes, Mononuclear / Q000187:drug effects* / Q000276:immunology; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D009000:Monocytes / Q000187:drug effects* / Q000276:immunology; D010936:Plant Extracts / Q000008:administration & dosage* / Q000737:chemistry; D018515:Plant Leaves / Q000737:chemistry; D011134:Polysaccharides / Q000008:administration & dosage* / Q000737:chemistry / Q000302:isolation & purification; D015398:Signal Transduction / Q000187:drug effects; D051197:Toll-Like Receptor 4 / Q000037:antagonists & inhibitors
chemical_list: D016207:Cytokines; D005685:Galactans; D010936:Plant Extracts; D011134:Polysaccharides; D051197:Toll-Like Receptor 4; C005653:arabinogalactan
references: J Immunotoxicol. 2011 Oct-Dec;8(4):288-97
references: 21770834
references: Int Immunopharmacol. 2009 Dec;9(13-14):1562-7
references: 19788935
references: Biochim Biophys Acta. 1991 Mar 4;1073(2):341-6
references: 2009282
references: J Ethnopharmacol. 2012 Jun 26;142(1):194-200
references: 22564815
references: Mar Drugs. 2011;9(9):1664-1681
references: 22131964
references: J Agric Food Chem. 2008 Nov 12;56(21):9892-8
references: 18841980
references: BMC Complement Altern Med. 2008 Jun 06;8:27
references: 18538006
references: Food Chem Toxicol. 2012 Jun;50(6):1951-4
references: 22497898
references: Biochim Biophys Acta. 1995 Apr 12;1235(1):10-20
references: 7718597
references: Protein J. 2011 Oct;30(7):509-19
references: 21953532
references: Biochemistry (Mosc). 2002 Dec;67(12):1371-6
references: 12600266
references: Biochem Pharmacol. 2012 Nov 15;84(10):1225-40
references: 22846603
references: Biotechniques. 1992 Feb;12(2):202-7, 210
references: 1616710
references: Planta Med. 1994 Jun;60(3):248-52
references: 17236043
references: Blood. 2008 Feb 1;111(3):1437-47
references: 17991807
references: Biosci Biotechnol Biochem. 2012;76(3):501-5
references: 22451391
references: J Immunol. 2005 Oct 1;175(7):4490-8
references: 16177092
references: Phytochemistry. 2005 Jan;66(1):5-29
references: 15649507
references: Int Immunopharmacol. 2003 Sep;3(9):1301-12
references: 12890428
references: Molecules. 2012 Aug 02;17(8):9142-206
references: 22858840
references: Int J Rheum Dis. 2010 Oct;13(4):396-405
references: 21199477
references: Immunol Lett. 2009 Mar 24;123(1):60-71
references: 19428553
references: J Agric Food Chem. 2010 Jan 27;58(2):927-36
references: 19916503
references: Vaccine. 2009 Jun 19;27(30):3984-91
references: 19389450
references: PLoS One. 2011 Feb 28;6(2):e17301
references: 21386979
references: Mar Biotechnol (NY). 2011 Jun;13(3):433-40
references: 20694826
references: Immunol Lett. 2011 Aug 30;138(2):169-78
references: 21524666
references: Biochem J. 1987 Jan 15;241(2):505-11
references: 3297033
references: Phytochemistry. 2008 Apr;69(6):1359-71
references: 18325553
references: BMC Complement Altern Med. 2011 Aug 28;11:72
references: 21871125
references: Int Immunopharmacol. 2007 Dec 15;7(13):1639-50
references: 17996673
references: Onkologie. 2002 Aug;25(4):374-80
references: 12232491
references: J Ethnopharmacol. 2007 Nov 1;114(2):246-53
references: 17888600
references: Int Immunopharmacol. 2008 Oct;8(10):1455-66
references: 18597716
references: Int Immunopharmacol. 2004 Nov;4(12):1477-87
references: 15351317
references: J Pharm Sci. 2011 Jan;100(1):34-7
references: 20575063
references: Nutr J. 2010 Nov 18;9:54
references: 21087484
references: Autoimmunity. 2002 Mar;35(2):111-7
references: 12071434
references: J Ethnopharmacol. 2004 Feb;90(2-3):221-7
references: 15013184
references: Exp Parasitol. 1986 Feb;61(1):103-13
references: 3943586
references: J Ethnopharmacol. 2009 Jul 30;124(3):481-7
references: 19467314
references: Clin Lung Cancer. 2011 May;12(3):143-7
references: 21663855
references: J Ethnopharmacol. 2008 Oct 28;119(3):664-72
references: 18640254
references: BMB Rep. 2012 Feb;45(2):79-84
references: 22360884
references: Biochim Biophys Acta. 2008 Jan;1780(1):51-7
references: 17961926
references: Comp Biochem Physiol B. 1992 Jul;102(3):445-9
references: 1499284
references: Carbohydr Res. 1995 Nov 7;277(1):67-85
references: 8548791
references: PLoS Pathog. 2012;8(3):e1002587
references: 22438809
references: Immunopharmacology. 1996 Mar;31(2-3):205-11
references: 8861746
references: J Immunol Methods. 2008 Jul 20;336(1):45-55
references: 18456276
references: FEMS Microbiol Lett. 2008 Jul;284(2):197-203
references: 18505412
references: Mediators Inflamm. 2012;2012:732860
references: 22474399
references: Appl Biochem Biotechnol. 1995 Dec;55(3):261-73
references: 8579345
references: Cancer Lett. 2010 Jan 1;287(1):1-12
references: 19487073
references: Expert Opin Ther Targets. 2010 Dec;14(12):1367-402
references: 21058924
references: Nat Prod Rep. 2009 Dec;26(12):1535-54
references: 19936385